Skip to main content
. Author manuscript; available in PMC: 2013 Mar 24.
Published in final edited form as: J Biomol Screen. 2012 Mar 29;17(5):651–661. doi: 10.1177/1087057112441521

Figure 1.

Figure 1

The NO/ADMA/DDAH Pathway and the pharmacological Inhibition of DDAH1 leading to higher ADMA levels and subsequent regulation of NO production. DMA = dimethylamine. ADMA = asymmetric Dimethylarginine. SDMA = symmetric Dimethylarginine. L-NMMA = monomethyl arginine. PRMTs = Protein Arginine Methyltransferases. NO = Nitric Oxide. NCE = New Chemical Entity